Drug-DNA recognition: energetics and implications for design.
about
Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulationsA structural insight into major groove directed binding of nitrosourea derivative nimustine with DNA: a spectroscopic studyThe complex of ethidium bromide with genomic DNA: structure analysis by polarized Raman spectroscopyShape readout of AT-rich DNA by carbohydrates.Revisiting the association of cationic groove-binding drugs to DNA using a Poisson-Boltzmann approach.Targeting of DNA molecules, BSA/c-Met tyrosine kinase receptors and anti-proliferative activity of bis(terpyridine)copper(ii) complexes.Experimental and computational studies on the effects of valganciclovir as an antiviral drug on calf thymus DNA.Synthesis and DNA-binding affinity studies of glycosylated intercalators designed as functional mimics of the anthracycline antibioticsMicroarray detection of duplex and triplex DNA binders with DNA-modified gold nanoparticles.A gold nanoparticle based approach for screening triplex DNA binders.Correlation Between Molecular Modelling and Spectroscopic Techniques in Investigation With DNA Binding Interaction of Ruthenium(II) Complexes.Spectroscopic, Viscositic, DNA Binding and Cytotoxic Studies of Newly Synthesized Steroidal Imidazolidines.Temperature dependence of the volumetric parameters of drug binding to poly[d(A-T)].Poly[d(A-T)] and Poly(dA).Poly(dT).Discriminating small molecule DNA binding modes by single molecule force spectroscopy.Thermodynamic analysis of quadruplex DNA-drug interaction.INTERACTION OF PORPHYRIN WITH G-QUADRUPLEX STRUCTURESNovel isothiacalothrixin B analogues exhibit cytotoxic activity on human colon cancer cells in vitro by inducing irreversible DNA damage
P2860
Q24811382-A2943E3C-8704-44E4-B6C8-45080D8DBE01Q28541713-47513B0C-EA5D-4B7B-8622-EF34AA5F526CQ33263366-92B9A17C-8F89-4549-ABFA-B7B07F600D72Q33954787-25EE317B-A658-4770-BCDC-79CBC0DD1798Q34032654-DC1A6D44-8E89-4845-A693-5F57FB9D4E6CQ35985323-BD3826C3-300D-4A8D-B1DF-CE8595B982B0Q36167461-F20822A4-F1B6-487C-B70A-AD183D6C7888Q36345568-14D2DC62-87B4-476E-881F-369A6A2EDD79Q38300263-A69999C8-C302-439D-8DBC-D42D6AA76165Q38314333-73FC2F72-38ED-456D-BDD3-1F1EFCF0C319Q39031106-1549E6C9-98B8-4410-9D2C-EACCA8DBE245Q40177142-2396307C-7771-4BB3-A337-78FFD32D5851Q42283178-0BA11462-BF8C-489E-B0EE-8F5C0FD3B865Q43717751-B821B6D8-6DDB-4B4B-AC58-D3B94681E1FEQ46860479-DCB09A8D-7419-4B14-A483-B14FD1305482Q56452877-CA792D3F-2069-49B2-9557-BBA5672B6D8AQ58762169-BA69E008-2CFF-468C-8E45-8D6D46FA9BDA
P2860
Drug-DNA recognition: energetics and implications for design.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug-DNA recognition: energetics and implications for design.
@ast
Drug-DNA recognition: energetics and implications for design.
@en
type
label
Drug-DNA recognition: energetics and implications for design.
@ast
Drug-DNA recognition: energetics and implications for design.
@en
prefLabel
Drug-DNA recognition: energetics and implications for design.
@ast
Drug-DNA recognition: energetics and implications for design.
@en
P2860
P1476
Drug-DNA recognition: energetics and implications for design.
@en
P2860
P304
P356
10.1002/1099-1352(200007/08)13:4<188::AID-JMR503>3.0.CO;2-1
P577
2000-07-01T00:00:00Z